series-c-plus
Stage
1
Investors
About
CASPR Biotech develops multi-cancer early detection tests using cell-free DNA analysis to identify cancer signals from a blood sample.
Explore CASPR Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.